mda-mb-468 glutathione content Small Peptide Ligands for Targeting EGFR in Triple Negative Breast Cancer Cells Using a novel panel of
Using a novel panel of drug resistant triple negative breast cancer cell lines to identify candidate therapeutic targets and biomarkers ScienceDirect RSL3 induces ferroptosis by activating the NF B signalling pathway to enhance the chemosensitivity of triple negative breast cancer cells to paclitaxel Scientific Reports Disclosing a metabolic signature of cisplatin resistance in MDA MB 231 triple negative breast cancer cells by NMR metabolomics Cancer Cell International Springer Nature Link Natural product preferentially targets redox and metabolic adaptations and aberrantly active STAT3 to inhibit breast tumor growth in vivo Cell Death & Disease
Pay in 4 interest-free payments of $5.86 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19



